NON-SMALL CELL LUNG CANCER STAGE IIIA
Clinical trials for NON-SMALL CELL LUNG CANCER STAGE IIIA explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CANCER STAGE IIIA trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCER STAGE IIIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to stop lung cancer from returning
Disease control OngoingThis study tests whether adding the drug durvalumab to targeted radiation (SBRT) can help keep early-stage non-small cell lung cancer from coming back. It included 13 people with stage I to IIIA disease. The main goal was to see how long they lived without their cancer getting wo…
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE IIIA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Could a cheaper keytruda copy work for lung cancer?
Disease control OngoingThis trial compares a biosimilar drug (SB27) to the standard cancer immunotherapy Keytruda in 163 people with stage II-IIIA non-small cell lung cancer who have already had surgery and chemotherapy. The main goal is to see if the body processes SB27 the same way as Keytruda. If su…
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE IIIA
Phase: PHASE1 • Sponsor: Samsung Bioepis Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC